If Andembry reaches the paediatric HAE market, it would have to contend with the best-seller Takhzyro and new oral option Orladeyo.

MapLight said the twice-daily dose met the primary endpoint of the schizophrenia trial, but the daily dose did not.

Eli Lilly is set for another win in the glucagon-like peptide-1 (GLP-1) sector as its triple-g agonist, retatrutide, has succeeded in type 2 diabetes and obesity. Marking the four ...

J&J's MonumenTAL-6 results add to the growing body of evidence touting Talvey and Tecvayli’s use in earlier multiple myeloma treatment lines.

China is rapidly overtaking the US in global oncology clinical trials, accounting for more than half of late-stage study activity by 2025.

Devonian Health Group has received authorisation from Health Canada for its CTA to begin a Phase II/III study of Thykamine cream to treat mild-to-moderate atopic dermatitis in paediatric patients.

The funds will help Crystalys progress its clinical-stage development efforts and commercialisation plans for its gout drug, dotinurad.

Bayer and Henry Ford Health intend to work together throughout clinical trials. Credit: Stock-Asso / Shutterstock.com. Bayer and Henry Ford Health have entered a strategic research partnership aimed ...

The study examines the safety, tolerability, and preliminary anti-tumour activity of IPH4502 in Nectin-4 expressing tumours. Credit: Gorodenkoff / Shutterstock.com. French company Innate Pharma has ...

Phase I accounts for approximately 43.6% of all Alzheimer’s disease trials, highlighting a strong influx of early stage candidates entering the pipeline. Credit: Only_NewPhoto via Shutterstock.com.